These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3010716)

  • 1. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
    Winston DJ; Ho WG; Nakao SL; Gale RP; Champlin RE
    Am J Med; 1986 May; 80(5):884-90. PubMed ID: 3010716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1990 Jan; 88(1):36-42. PubMed ID: 2153006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
    Winston DJ; Ho WG; Champlin RE; Karp J; Bartlett J; Finley RS; Joshi JH; Talbot G; Levitt L; Deresinski S
    Am J Med; 1987 Jun; 82(6B):40-6. PubMed ID: 3037899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin for infection prophylaxis in granulocytopenic patients with acute leukemia.
    Cortellaro M; Cofrancesco E; Pasargiklian I; Bianchi R; Pozzoli E; Annaloro C; Ranzi ML; Mascheroni E; Polli N
    Haematologica; 1990; 75(6):541-5. PubMed ID: 2098296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.
    Nemet D; Kalenic S; Badanjak A; Bogdanic V; Davila N; Francetić I; Labar B
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():105. PubMed ID: 2697389
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoprophylaxis of bacterial infections in granulocytopenic cancer patients using norfloxacin.
    Casali A; Verri C; Paoletti G; Tropea F; Modugno G; Frasca AM; Ameglio F; Tonachella R; Gallo Curcio C
    Chemioterapia; 1988 Oct; 7(5):327-9. PubMed ID: 3066518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.
    Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
    Ann Intern Med; 1987 Jan; 106(1):1-7. PubMed ID: 3538962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient.
    Karp JE; Dick JD; Merz WG
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S5-13. PubMed ID: 3127219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of bacterial and fungal infections in granulocytopenic patients.
    Verhoef J; Rozenberg-Arska M; Dekker AW
    Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1345-50. PubMed ID: 2680513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.
    Cruciani M; Concia E; Navarra A; Perversi L; Bonetti F; Aricò M; Nespoli L
    Infection; 1989; 17(2):65-9. PubMed ID: 2654019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.
    Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
    Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study.
    Orlandi E; Navarra A; Cruciani M; Caldera D; Morra E; Castagnola C; Concia E; Bernasconi C
    Haematologica; 1990; 75(3):296-8. PubMed ID: 2227631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Wiesneth M; Bunjes D; Hertenstein B; Kern W; Heit W; Heimpel H
    Scand J Infect Dis; 1988; 20(6):625-31. PubMed ID: 3065930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
    Wade JC; de Jongh CA; Newman KA; Crowley J; Wiernik PH; Schimpff SC
    J Infect Dis; 1983 Apr; 147(4):624-34. PubMed ID: 6842003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia.
    Kern W; Kurrle E
    Infection; 1991; 19(2):73-80. PubMed ID: 2050424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.
    Maschmeyer G; Haralambie E; Gaus W; Kern W; Dekker AW; De Vries-Hospers HG; Sizoo W; König W; Gutzler F; Daenen S
    Infection; 1988; 16(2):98-104. PubMed ID: 3286509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis.
    Classen DC; Burke JP; Ford CD; Evershed S; Aloia MR; Wilfahrt JK; Elliott JA
    Am J Med; 1990 Oct; 89(4):441-6. PubMed ID: 2171333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.
    Sleijfer DT; Mulder NH; de Vries-Hospers HG; Fidler V; Nieweg HO; van der Waaij D; van Saene HK
    Eur J Cancer (1965); 1980 Jun; 16(6):859-69. PubMed ID: 6997054
    [No Abstract]   [Full Text] [Related]  

  • 19. Gram-positive infections in granulocytopenic patients: an important issue?
    Viscoli C; Van der Auwera P; Meunier F
    J Antimicrob Chemother; 1988 Apr; 21 Suppl C():149-56. PubMed ID: 3290182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
    J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.